Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share 2026’s most pressing workforce challenges and their solutions. The 16 executives featured in this article are all speaking at the Becker’s Healthcare Spring Chief Pharmacy Officer…
Pharmacy
A CommonSpirit hospital in Tacoma, Wash., plans to build a 16-bed infusion center in an unoccupied suite, according to permits filed with the city. The hospital, St. Joseph Medical Center, is part of Virginia Mason Franciscan Health, a member of…
After CVS Health surpassed its projected operating income for 2025, the company increased annual bonuses for corporate employees about 42% higher than baseline levels, Bloomberg reported Feb. 23. The bonuses for 2025 are based on net promoter score, how CVS…
The FDA has approved Bysanti (milsaperidone) tablets for the treatment of bipolar I disorder and schizophrenia in adults. The drug is indicated as a first-line therapy for acute manic or mixed episodes associated with bipolar I disorder, as well as…
Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the latter’s Erleada. The suit, filed in the U.S.…
Advertisement
In a deal worth $7.8 billion, Gilead Sciences has entered a definitive agreement to acquire Arcellx, a biotech company developing a cell therapy for multiple myeloma. Gilead announced the acquisition agreement a few months after Arcellx published positive data from…
In 2025, 85.7% of pharmacy school graduates passed the North American Pharmacist Licensure Examination on their first attempt, according to data from the National Association of Boards of Pharmacy. The NAPLEX assesses an individual’s competence to practice as a pharmacist…
New York City-based Mount Sinai Health System’s pharmacy leaders are no longer debating whether to adopt AI. The question now is where to focus — and how to move from exploration to execution without introducing friction into daily workflows. “We…
Louisiana Attorney General Liz Murrill has reached a $45 million settlement with CVS Health and its pharmacy benefit manager subsidiary, resolving three lawsuits over alleged regulatory and competitive misconduct. The lawsuits concerned allegations related to consumer communications about pending legislation,…
The FDA has released draft guidance outlining an approval pathway for individualized therapies aimed at ultra-rare diseases, building on a framework first outlined by agency leaders in November. The proposed pathway, dubbed the “Plausible Mechanism Framework,” would allow sponsors to…